Timberland Partners With Christopher Raeburn

Timberland reveals an alliance with British designer Christopher Raeburn, who will serve as Global Creative Director.  Raeburn's label embodies smart and responsible fashion design.  Christopher will be an essential contributor to Timberland's global creative vision.  Assuring holistic design across all product categories, marketing, and in-store environments.  Elevating a commitment to responsible sourcing, inclusion, and community.  
   
The three pillars of Raeburn's design ethos are remade, reduced, recycled.  These complement Timberland's enduring commitment to responsible manufacturing.  Steadily increasing use of recycled, organic, and renewable materials.  Raeburn also signals craftsmanship, innovation, and utility as central to his design philosophy.  These being natural and authentic connections to the Timberland® brand.
   
As creative director, Raeburn will work with Timberland's global product, marketing, and innovation teams.  Delivering a radical look and feel that pushes design edges while honoring the marque's outdoor heritage.  Raeburn will work with each team to create a collection of Timberland® footwear, apparel, and accessories.  Furthering the principle to step outside, work together, and make it better.  The first full collection under Raeburn's conception will be fall/winter 2020.
   
 Jim Pisani, global brand president, said: 'Timberland has a strong foundation in craftsmanship and innovation; now it's time to elevate our brand vision through the lens of design.  Christopher Raeburn is a true visionary, who shares our ethos of responsibility and brings to the table a fresh, modern design sensibility.  Together we will push the boundaries of where Timberland can go as a brand, and we're excited to get started.'
   
Christopher Raeburn said: 'I've been watching the Timberland® brand for years and have always admired its commitment to be a responsible business.  I see an incredible opportunity for Timberland to break out and put responsible, innovative design at the center of the brand's creative strategy.  It's an exciting moment to join forces with Timberland; a company set to evolve following decades of good work.  I'm honored to be partnering with a company with such strong values and I'm truly excited to be making a difference on a global scale.'
   
Raeburn will divide his time between his Christopher RÆBURN label and Timberland.  Christopher will be based in his London studio, traveling often to Timberland's global headquarters in Stratham, New Hampshire, and regional headquarters in Stabio, Switzerland and Hong Kong. 
   
Timberland and Raeburn first collaborated on a global apparel capsule collection that debuted earlier this year at London Fashion Week and launches in stores and online today.  In keeping with his REMADE philosophy, Raeburn scoured street markets and second-hand shops to find vintage Timberland® items.  He then meticulously deconstructed and remade these into seminal pieces for the runway.  These, in turn, served as inspiration for the Timberland x Christopher RÆBURN capsule collection of outerwear, pants, shirts, and t-shirts launching today.  Each garment incorporates a range of eco-conscious materials like organic cotton and recycled PET, abating environmental impact.

Comments

Post a Comment

Popular posts from this blog

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. Their product range now includes wood
Read more

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy PepsiCo products a billion times a
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address the limitations of current st
Read more